In consideration of health concerns resulting from COVID-19, the Society for Immunotherapy of Cancer (SITC), in collaboration with program organizers, has made the decision to postpone the Cytokines in Cancer Immunotherapy Workshop until 2021. This page will be updated with more details as they become available.
ORGANIZERS
- Susan M. Kaech, PhD – Salk Institute
- Anne O' Garra, PhD – The Francis Crick Institute
- Aaron Ring, MD, PhD – Yale University
The Society for Immunotherapy of Cancer (SITC) invites you to attend the workshop, Cytokines in Cancer Immunotherapy. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches.
The workshop will consist of scientific sessions and expert-led discussion by invited faculty on pressing topics in the field of cytokines in immunology and cancer immunotherapy. This workshop will encourage further investigation into the use of cytokines as solo therapeutic agents as well as in combination with cancer treatments by bringing together established experts and drawing talented new scientists and clinicians into the area of cytokines and immune cell differentiation and function.
It is anticipated that the efforts of this workshop will foster renewed exchange and research on the promising topic of cytokines and their interactions in cancer development and therapy, lead to further research, and provide a solid scientific foundation for future clinical interventions to modulate anti-tumor immunity with combinations of cytokines and other immunotherapies.
Topics to be discussed during this workshop will include:
- History of cytokine immunotherapy
- Designer Cytokines
- Paradox of IL-10
- Inhibitory cytokines
- Interferons: Friend or foe?
- Clinical trials with cytokines
- Emerging cytokine therapies
- Cytokines in cellular therapies
- Cytokines in innate immunity
Workshop Target Audience
Learning Objectives
- Describe the mechanisms of cytokines in the differentiation, activation, and function of immune cells
- Summarize current clinical and preclinical studies of cytokines as cancer immunotherapies and in combination with other cancer therapies
- Explain the use of cytokines in adoptive cellular therapies
abstracts welcome
- All prospective attendees are encouraged to submit an abstract of their current work to be featured in a networking poster session that brings together early career and established scientists working in the cytokine space.
- A portion of the workshop will be dedicated to early career scientists, wherein 20 early career investigators who are selected through a review of abstract submissions will orally present their cytokine-related research.
- The top ten abstracts submitted from early career scientists will be selected for oral presentations interspersed throughout the workshop.
- Another ten abstract presentations will be structured in a “Minute to Win It” format, wherein early career presenters are given one minute to discuss their results.
- The presentations (both oral and rapid) will be judged and the top two will be honored with a small monetary award for their labs or research projects.